Freedom Foods Group Ltd reports profit drop: Is this growth stock a buy?

Freedom Foods Group Ltd (ASX:FNP) will need to produce significantly higher future earnings to justify its share price.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Freedom Foods Group Ltd (ASX: FNP) was amongst a large handful of companies to wait until after 5pm last Friday to announce to the market its half -year financial results.

For readers unfamiliar with Freedom Foods, the group boasts a market capitalisation of $500 million and is a niche manufacturer of allergen-free healthy foods including cereal and spreads.

For the half year ending 31 December 2014, the group achieved an 8.3% increase in net sales revenue to $55.5 million. On a statutory basis, reported profits were huge thanks to a fair value gain on the group's investment in the New Zealand-based a2 Milk Company. On an underlying basis however, operating net profit after tax fell 24.9% to $3.1 million and the corresponding earnings per share fell 26.2% to 2.04 cents per share.

Not Great

The underlying profit result could hardly be described as great, however as management noted: "Profitability (was) impacted by commissioning of the new nutritional snack equipment reducing manufacturing recoveries and gross margin during the half."

This investment for future growth included a $9 million expenditure on upgrading capacity including the installation of a new state of the art automated nutritional snack line.

Freedom also invested in expanding its North American sales and distribution capabilities in readiness for plans to launch new products into this market.

Outlook

Management didn't exactly quantify what investors should expect for the full year, however, they did state that they anticipate: "Growth in sales and profits over the remainder of financial year (FY) 2015, with the benefits of its multi stage capital investment programme delivering increased profits and returns from FY 2016 and beyond."

Given the company already commands a market capitalisation of over $500 million, investors will want to be confident that current spending will boost future earnings significantly as this is required to justify the hefty multiple that they are currently being asked to pay.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned.  

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »